ISRCTN14825568已完成不适用
Ovarian stimulation with follicle stimulating hormone (r-FSH) for women with high early follicular FSH and intra-uterine insemination (IUI) indicatio
VU University Medical Centre (VUMC) (Netherlands)0 个研究点目标入组 80 人开始时间: 2006年2月14日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Women with elevated early follicular FSH (cycle day 2-4)
- •2. Women between 18 and 45 years
- •3. Regular menstrual cycle between 25 and 35 days
- •4. Indication for IUI treatment
- •5. Normal hysterosalpingography
- •6. Normal serum Ca-125
- •7. Semen analyses: >2 million progressive motile spermatozoa
- •8. Ovulatory cycle
排除标准
- •1. Untreated other endocrinal pathology
- •2. Abnormal vaginal blood loss of unknown origin
- •3. Contra-indications for use of r-FSH or human choronic gonadotropin (hCG)
- •4. Contra-indications for pregnancy
- •5. Congenital uterus anomaly
- •6. Endometriosis more than stage II (revised ASRM score)
研究者
相似试验
已完成
2 期
FSH effect in OHSS preventioOHSS.Hyperstimulation of ovariesIRCT201407206063N3Tehran University of Medical Science and Health Service70
进行中(未招募)
1 期
uteal phase ovarian stimulation with Follitropin delta and dydrogesteroneVolutary women who wish to donate their oocytesCTIS2024-513998-48-00niversitair Ziekenhuis Brussel50
进行中(未招募)
1 期
uteal phase ovarian stimulation with Follitropin delta and dydrogesteroneVolutary women who wish to donate their oocytesEUCTR2022-003049-37-BEZ Brussel50
进行中(未招募)
1 期
Initiation of ovarian stimulation in the late follicular phaseSubfertility Oocyte donationMedDRA version: 20.0 Level: LLT Classification code 10042392 Term: Subfertility (female) System Organ Class: 100000004872MedDRA version: 20.0 Level: PT Classification code 10053370 Term: Oocyte donation System Organ Class: 10042613 - Surgical and medical proceduresEUCTR2017-005005-12-BEZ Brussel62
进行中(未招募)
1 期
Protocol with Progestin-primed Ovarian Stimulation (PPOS) in conventional treatment from the start of stimulation vs protocol with GnRH antagonists as a pituitary suppressor in patients who are going to undergo DUOSTIM with embryo accumulation for PGT-A of the embryos.CTIS2023-508769-33-00Ginefiv S.L.144
